Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Focal to market directly in North America

This article was originally published in Clinica

Executive Summary

Focal, the manufacturer of the FocalSeal surgical sealant line, has decided to market the product directly in the US and Canada, rather than employ a marketing partner as it does in Europe. FocalSeal is not yet approved in the US, although a PMA application for the use of FocalSeal-L (long-term absorbable) in lung surgery was granted expedited review by the FDA in April. The company recently submitted the final part of the application.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078836

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel